Why Is Hims & Hers Health Stock Surging on Thursday?
Hims & Hers Health Inc (NYSE: HIMS) stock surges Thursday after an FDA advisory committee votes on adding BPC-157 to the allowed pharmacy compounding list.
A government group voted to allow pharmacies to mix a new medicine called BPC-157, which Hims & Hers sells. This is good news for the company because more people might be able to buy it, so investors got excited about the stock.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.